|
|
(These articles have been accepted for this issue. Change is possible before publication.)
Receive this page by email each issue:
[Sign up for eTOCs]
June 1, 2008; 111 (11)
ASH 50TH ANNIVERSARY REVIEW
- D. D. Wagner and P. S. Frenette
- The vessel wall and its interactions
PLENARY PAPER
- V. Babich, A. Meli, L. Knipe, J. E. Dempster, P. Skehel, M. J. Hannah, and T. Carter
- Selective release of molecules from Weibel-Palade bodies during a lingering kiss
CLINICAL TRIALS AND OBSERVATIONS
- A. Ferrajoli, B.-N. Lee, E. J. Schlette, S. M. O'Brien, H. Gao, S. Wen, W. G. Wierda, Z. Estrov, S. Faderl, E. N. Cohen, C. Li, J. M. Reuben, and M. J. Keating
- Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
HEMATOPOIESIS AND STEM CELLS
- N. Takayama, H. Nishikii, J. Usui, H. Tsukui, A. Sawaguchi, T. Hiroyama, K. Eto, and H. Nakauchi
- Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
- A.-l. Stahl, F. Vaziri-Sani, S. Heinen, A.-C. Kristoffersson, K.-H. Gydell, R. Raafat, A. Gutierrez, O. Beringer, P. F. Zipfel, and D. Karpman
- Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation
- A. Gaultier, S. Arandjelovic, S. Niessen, C. D. Overton, M. F. Linton, S. Fazio, W. M. Campana, B. F. Cravatt III, and S. L. Gonias
- Regulation of tumor necrosis factor receptor-1 and the IKK-NF-
 B pathway by LDL receptor-related protein explains the antiinflammatory activity of this receptor
IMMUNOBIOLOGY
- C. S. Hinrichs, R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo
- IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
- D. Saadoun, M. Rosenzwajg, D. Landau, J. C. Piette, D. Klatzmann, and P. Cacoub
- Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis
- C. I.-U. Chen, H. T. Maecker, and P. P. Lee
- Development and dynamics of robust T-cell responses to CML under imatinib treatment
NEOPLASIA
- L. Paoluzzi, M. Gonen, J. R. Gardner, J. Mastrella, D. Yang, J. Holmlund, M. Sorensen, L. Leopold, K. Manova, G. Marcucci, M. L. Heaney, and O. A. O'Connor
- Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma
- S. Mittal, N. A. Marshall, L. Duncan, D. J. Culligan, R. N. Barker, and M. A. Vickers
- Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
- C. Langer, M. D. Radmacher, A. S. Ruppert, S. P. Whitman, P. Paschka, K. Mrozek, C. D. Baldus, T. Vukosavljevic, C.-G. Liu, M. E. Ross, B. L. Powell, A. de la Chapelle, J. E. Kolitz, R. A. Larson, G. Marcucci, and C. D. Bloomfield
- High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study
RED CELLS
- A. M. Toye, R. C. Williamson, M. Khanfar, B. Bader-Meunier, T. Cynober, M. Thibault, G. Tchernia, M. Dechaux, J. Delaunay, and L. J. Bruce
- Band 3 Courcouronnes (Ser667Phe): a trafficking mutant differentially rescued by wild-type band 3 and glycophorin A
- P. Sathyanarayana, A. Dev, J. Fang, E. Houde, O. Bogacheva, O. Bogachev, M. Menon, S. Browne, A. Pradeep, C. Emerson, and D. M. Wojchowski
- EPO receptor circuits for primary erythroblast survival
- M. J. Percy, P. A. Beer, G. Campbell, A. W. Dekker, A. R. Green, D. Oscier, M. G. Rainey, R. van Wijk, M. Wood, T. R. J. Lappin, M. F. McMullin, and F. S. Lee
- Brief report. Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis
TRANSPLANTATION
- D. J. Winston, J.-A. H. Young, V. Pullarkat, G. A. Papanicolaou, R. Vij, E. Vance, G. J. Alangaden, R. F. Chemaly, F. Petersen, N. Chao, J. Klein, K. Sprague, S. A. Villano, and M. Boeckh
- Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
| |
